ProPhase Labs, Inc. — Investor Relations & Filings
Filings indexed
646
across all filing types
Latest filing
2026-03-27
Regulatory Filings
Country
US
United States of America
Listing
US
PRPH
ProPhase Labs, Inc. is a diversified biotechnology, genomics, and diagnostics company focused on developing, manufacturing, and commercializing health and wellness solutions. The company operates CLIA-certified laboratories to provide diagnostic and genomics testing services for healthcare providers and consumers. In addition to its diagnostics and genomics operations, ProPhase Labs offers contract manufacturing services and develops dietary supplements and other consumer health products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NT 10-K | 2026-03-27 | English | |
| 8-K Filing | 2026-02-13 | English | |
| 8-K Filing | 2026-02-13 | English | |
| 8-K Filing | 2026-01-27 | English | |
| 8-K Filing | 2026-01-23 | English | |
| 25-NSE Filing | 2026-01-23 | English |
Browse filings by year
31 years- 2026 10 filings
- 2025 59 filings
- 2024 36 filings
- 2023 39 filings
- 2022 42 filings
- 2021 40 filings
- 2020 40 filings
- 2019 22 filings
- 2018 35 filings
- 2017 50 filings
- 2016 12 filings
- 2015 43 filings
- 2014 31 filings
- 2013 25 filings
- 2012 28 filings
- 2011 52 filings
- 2010 37 filings
- 2009 13 filings
- 2008 3 filings
- 2007 1 filing
- 2006 4 filings
- 2005 3 filings
- 2004 4 filings
- 2003 6 filings
- 2002 1 filing
- 2001 2 filings
- 2000 1 filing
- 1999 1 filing
- 1998 2 filings
- 1997 2 filings
- 1996 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46143913 | NT 10-K | 2026-03-27 | English | ||
| 24582559 | 8-K Filing | 2026-02-13 | English | ||
| 24582327 | 8-K Filing | 2026-02-13 | English | ||
| 24582500 | 8-K Filing | 2026-01-27 | English | ||
| 24582489 | 8-K Filing | 2026-01-23 | English | ||
| 24582381 | 25-NSE Filing | 2026-01-23 | English | ||
| 24582321 | 8-K Filing | 2026-01-23 | English | ||
| 24582531 | 8-K Filing | 2026-01-09 | English | ||
| 24582304 | 8-K Filing | 2026-01-09 | English | ||
| 24582445 | 8-K Filing | 2026-01-02 | English | ||
|
2025
5 filings
| |||||
| 24582444 | 424B5 Filing | 2025-12-29 | English | ||
| 24582537 | 424B5 Filing | 2025-12-19 | English | ||
| 24582263 | 8-K Filing | 2025-12-19 | English | ||
| 24582233 | 8-K Filing | 2025-12-19 | English | ||
| 24582614 | 8-K/A Filing | 2025-12-18 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
ProPhase Labs, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34999/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34999 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34999 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34999 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34999}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ProPhase Labs, Inc. (id: 34999)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.